• MEPS veto Commission proposal for criteria to identify disruptors
  • oppose exempting substances that are designed to have an endocrine disrupting effect
  • European Commission will have to come up with a new proposal without delay

 

Some pesticides contain endocrine disruptors despite the fact that they are considered "a global threat" by a recent UN report©AP Images/EU 

Parliament blocked an EU Commission proposal which would have exempted some chemicals in pesticides from being identified as endocrine disruptors, on Wednesday.

MEPs say that the Commission exceeded its mandate by proposing to exempt substances which are actually designed to attack an organism’s endocrine system, e.g. in pests, from the identification criteria.

Next steps

The objection, proposed by MEPs Jytte Guteland and Bas Eickhout, was approved by  389 votes to 235, with 70 abstentions, producing the absolute majority needed to block the proposal. The European Commission will therefore have to draft a new version of the text, taking into account Parliament’s input.

Quick Facts

EU legislation requires that pesticides or biocide substances have no endocrine-disrupting effects on other species than the ones targeted. To apply  this legislation, the EU needs a list of scientific criteria for identifying endocrine disruptors.

The Commission proposal related to the scientific criteria for identifying endocrine-disrupting properties of chemical substances. The identification of these scientific criteria is a first step towards measures reducing their presence and protecting citizens’ health.

The European Court of Justice ruled in December 2015 that the EU Commission had breached EU law by failing to publish criteria for determining endocrine disrupters due at the end of 2013. MEPs have repeatedly urged the EU to clamp down on the substances.

A UNEP/WHO report called endocrine disruptors a “global threat”, referring inter alia to the upward trends in many endocrine-related disorders in humans and wildlife populations. There is evidence of adverse reproductive effects (infertility, cancers, malformations) which could also affect thyroid function, brain function, obesity, metabolism, insulin and glucose homeostasis, it says.